HK1063017A1 - Microgranules based on active principle and methodfor making same - Google Patents

Microgranules based on active principle and methodfor making same

Info

Publication number
HK1063017A1
HK1063017A1 HK04105869D HK04105869D HK1063017A1 HK 1063017 A1 HK1063017 A1 HK 1063017A1 HK 04105869 D HK04105869 D HK 04105869D HK 04105869 D HK04105869 D HK 04105869D HK 1063017 A1 HK1063017 A1 HK 1063017A1
Authority
HK
Hong Kong
Prior art keywords
active principle
making same
microgranules
core
methodfor
Prior art date
Application number
HK04105869D
Other languages
English (en)
Inventor
Etienne Bruna
Edouard Gendrot
Gerard Cousin
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of HK1063017A1 publication Critical patent/HK1063017A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micromachines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04105869D 2000-11-16 2004-08-06 Microgranules based on active principle and methodfor making same HK1063017A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014803A FR2816507B1 (fr) 2000-11-16 2000-11-16 Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
PCT/FR2001/003584 WO2002039981A1 (fr) 2000-11-16 2001-11-15 Microgranules a base de principe actif et leur procede de fabrication

Publications (1)

Publication Number Publication Date
HK1063017A1 true HK1063017A1 (en) 2004-12-10

Family

ID=8856551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105869D HK1063017A1 (en) 2000-11-16 2004-08-06 Microgranules based on active principle and methodfor making same

Country Status (15)

Country Link
US (1) US7829122B2 (da)
EP (1) EP1333812B1 (da)
JP (1) JP4234427B2 (da)
CN (1) CN1222277C (da)
AT (1) ATE387187T1 (da)
AU (2) AU2002223074B2 (da)
CA (1) CA2427899C (da)
DE (1) DE60133028T2 (da)
DK (1) DK1333812T3 (da)
ES (1) ES2300384T3 (da)
FR (1) FR2816507B1 (da)
HK (1) HK1063017A1 (da)
MX (1) MXPA03004300A (da)
PT (1) PT1333812E (da)
WO (1) WO2002039981A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
CN103040773A (zh) * 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
SG158869A1 (en) * 2005-01-21 2010-02-26 Warner Chilcott Co Llc A tetracycline metal complex in a solid dosage form
CN101912360A (zh) * 2010-07-13 2010-12-15 山东达因海洋生物制药股份有限公司 布洛芬混悬液及其制备方法
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8568776B2 (en) 2011-02-11 2013-10-29 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
DE102012007671A1 (de) * 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CA2881992C (en) 2013-04-23 2016-11-22 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
KR102019645B1 (ko) * 2019-02-21 2019-09-09 한국화학연구원 염기성오염물질 제거용 비드 및 이의 제조방법
CN111184694A (zh) * 2020-01-19 2020-05-22 广东青云山药业有限公司 一种口腔速溶颗粒的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
IT1115596B (it) 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
DE69530973T2 (de) 1994-02-16 2004-05-19 Abbott Laboratories, Abbott Park Verfahren zur herstellung feinteiliger pharmazeutischer formulierungen
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
CN1481235A (zh) 2004-03-10
PT1333812E (pt) 2008-03-17
ATE387187T1 (de) 2008-03-15
MXPA03004300A (es) 2004-09-10
US7829122B2 (en) 2010-11-09
AU2307402A (en) 2002-05-27
DE60133028T2 (de) 2009-03-12
DE60133028D1 (de) 2008-04-10
ES2300384T3 (es) 2008-06-16
CA2427899C (fr) 2011-05-10
FR2816507B1 (fr) 2003-02-28
DK1333812T3 (da) 2008-03-31
AU2002223074B2 (en) 2005-03-10
CA2427899A1 (fr) 2002-05-23
JP4234427B2 (ja) 2009-03-04
WO2002039981A1 (fr) 2002-05-23
FR2816507A1 (fr) 2002-05-17
US20040101568A1 (en) 2004-05-27
CN1222277C (zh) 2005-10-12
EP1333812B1 (fr) 2008-02-27
EP1333812A1 (fr) 2003-08-13
JP2004517064A (ja) 2004-06-10

Similar Documents

Publication Publication Date Title
HK1063017A1 (en) Microgranules based on active principle and methodfor making same
ES2157731A1 (es) Preparacion farmaceutica oral de un compuesto de anticidad antifungica y procedimiento para su preparacion.
ES2130666T3 (es) Procedimiento de revestimiento de particulas.
IL151150A0 (en) Multiparticulate drug form comprising at least two differently coated pellet forms
AU8865998A (en) Improved multiparticulate tablet with quick disintegration
MXPA03003545A (es) Metodo para elaborar articulos revestidos, y los articulos revestidos a partir del mismo.
ZA997058B (en) Game machine and method of controlling the same.
WO2004030652A3 (en) Dosage form having an inner core and at least two coating layers
BG105484A (en) Implant with cavitiies containing therapeutic agents
CA2255891A1 (en) Compositions and methods for treating or preventing diseases of body passageways
MXPA05008161A (es) Composicion que comprende una mezcla de principios activos, y metodo de preparacion.
IL137536A0 (en) Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
GB2337938A (en) Golf ball and method of making same
AU4683397A (en) Composite melanin pigment in the form of particles comprising a wax-based spherical core, preparation processes and cosmetic uses
GB2343117A (en) Benzimidazole pharmaceutical composition and process of preparation
NO20011903L (no) Partikler
AU2002223074A1 (en) Microgranules based on active principle and method for making same
GB2337937A (en) Golf ball comprising a metal mantle having a hollow interior
WO2002072072A3 (fr) Granules et granules enrobes au gout masque
HUP0101379A2 (hu) Klór-fehérítőszereket tartalmazó mosogatószer-formatest
WO1998049985A3 (en) Novel casting tape article and method for molding casts
WO2002060135A3 (en) Approach for transferring functions between participants in a communications arrangement
AU6703696A (en) Method for making granules, and resulting granules
WO2002080706A3 (en) Improved delivery of benefit agents
CA2259407A1 (en) Drug delivery devices and process of manufacture

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20211114